Lumenis introduces the Photofacial treatment

05 Apr 2018

Lumenis has launched the Photofacial that combines existing M22, IPL and ResurFX treatments.

The M22 is designed to minimise downtime and aims to help with skin rejuvenation, collagen stimulation, pigmented and vascular lesions, active acne treatment, scarring and stretch mark removal. Lumenis claims the ResurFX can resurface the skin and still protect deeper, vulnerable elements. The laser is a non-ablative treatment, that stimulates the production of collagen and elastic fibers. 

According to the company, the aim of combining the M22, IPL and ResurFX treatments is to significantly improve the tone and texture of the skin, tackle fine lines and wrinkles, acne, pigmentation, scarring and thread veins. 

The multiple functions in one treatment means that the treatment takes less time, with minimal downtime and is completely bespoke dependent on the skin conditions and skin type.

Aesthetic practitioner Dr Benji Dhillon, who performs the treatments at PHI Clinic, said, “Treatments like Lumenis M22, ResurFX and IPL ensure the skin is functioning optimally, increasing the skin’s luminosity and radiance. This improves the health of the skin for a natural rejuvenation. There is minimal downtime to these treatments ensuring they suit patients’ lifestyle choices.”

Lumenis will be holding a Masterclass and Exhibiting at ACE 2018 on Friday April 27 at 3-4pm. 


Log-in to post a comment